Toll-Free: 855-947-0707
Phone: 202-796-6662
Kennedy Hodges L.L.P.

Cholesterol Drug Recalled due to Defective Packaging

Comments (0)

A new cholesterol drug, Liptruzet, manufactured by Merck, has been recalled because of problems with packaging. According to Merck, the foil pouches the pills are contained in could allow air and moisture inside, which could decrease the drug's effectiveness. The drug hit the market in May and all pills that have been sold are subject to the recall.

Liptruzet is a combination of two drugs that are intended to reduce bad cholesterol levels. Fortunately, no health problems are expected to result from the recall. Both drugs that make up Liptruzet will continue to be available during the recall. Also, since the drug has been on the market less than a year, it most likely has not been widely prescribed. Any Lipruzet that patients have on hand can still be taken, according to experts, and they shouldn't quit taking it without talking to their doctors.

The real danger of the recall, according to doctors, is that patients will stop taking their cholesterol medication altogether because they believe that there is nothing to replace the medication. However, a much cheaper drug called atorvastatin can be used in its place in most cases. Liptruzet costs about $5.50 per pill, and atorvastatin is less than 25 cents per pill.

Although this drug recall doesn't appear to be very dangerous, many others are. If you have been injured by a defective recalled drug, call Kennedy Hodges at 713-489-9493. Our Texas defective drug attorneys have substantial experience in working with victims of recalled drugs. You can learn more about us on LinkedIn.

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."

Name:*

Email:* (will not be published)

Message:*

Notify me of follow-up comments via email.

Live Chat